# Liraglutide Treatment in Obese Infertile PCOS Women

> **NCT06742710** · PHASE4 · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 890 (estimated)

## Conditions studied

- PCOS
- Obesity
- Infertility

## Interventions

- **DRUG:** Liraglutide and metformin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06742710
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-22
- **Primary completion:** 2029-05-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 890 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06742710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06742710, "Liraglutide Treatment in Obese Infertile PCOS Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06742710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*